Database and news
Peptides
Research peptides, clinic marketing, access and quality risk coverage
Peptide regulatory status tracker
Where each peptide stands with FDA: its 503A bulks-list status, any FDA-approved product, advisory committee votes and anti-doping status, with the source for every change.
- FDA-approved Sexual & reproductive
Cetrorelix
Cetrorelix is an FDA-approved GnRH antagonist sold as Cetrotide. Learn how it prevents early ovulation during IVF stimulation and where it fits.
- FDA-approved Sexual & reproductive
Degarelix
Degarelix is an FDA-approved GnRH antagonist for advanced prostate cancer that lowers testosterone quickly. Learn how it works and its side effects.
- FDA-approved Sexual & reproductive
Ganirelix
Ganirelix is an FDA-approved GnRH antagonist peptide that prevents early ovulation during IVF. Learn how it works, what it is used for, and its side effects.
- FDA-approved Sexual & reproductive
Goserelin
Goserelin (Zoladex) is an FDA-approved GnRH agonist implant. Learn how it lowers sex hormones and what it is used for in cancer and endometriosis.
- FDA-approved Sexual & reproductive
Histrelin
Histrelin is an FDA-approved GnRH agonist implant for central precocious puberty. Learn how it works, its side effects, and the evidence behind it.
- FDA-approved Sexual & reproductive
Human chorionic gonadotropin
hCG is an FDA-approved hormone that mimics luteinizing hormone. Learn its approved uses, how it works, its risks, and why it is not approved for weight loss.
- FDA-approved Sexual & reproductive
Leuprolide
Leuprolide is a GnRH agonist FDA-approved since 1985. It suppresses testosterone and estrogen for prostate cancer, endometriosis, and precocious puberty.
- FDA-approved Sexual & reproductive
Lutetium Lu-177 vipivotide tetraxetan
Pluvicto
Lu-177 vipivotide tetraxetan (Pluvicto) is an FDA-approved radiation therapy for PSMA-positive prostate cancer. See how it works and side effects.
- FDA-approved Sexual & reproductive
Nafarelin
Synarel
Nafarelin is an FDA-approved GnRH agonist nasal spray for endometriosis and central precocious puberty. See how it works and what trials show.
- FDA-approved Sexual & reproductive
Oxytocin
Oxytocin is a nine-amino-acid pituitary hormone. Learn how it makes the uterus contract, why it is FDA-approved for labor, and its side effects.
- FDA-approved Sexual & reproductive
Triptorelin
Triptorelin is an FDA-approved GnRH agonist given as a depot injection. Learn its approved uses, how it lowers testosterone, and what trials show.
| Peptide | Status | 503A bulks list | FDA-approved product | WADA |
|---|---|---|---|---|
| Cetrorelix | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Degarelix | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Ganirelix | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Goserelin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Histrelin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Human chorionic gonadotropin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Leuprolide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Lutetium Lu-177 vipivotide tetraxetan Pluvicto | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Nafarelin Synarel | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Oxytocin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Triptorelin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
Source: FDA 503A bulks-list categories, PCAC meeting materials and the WADA Prohibited List
Status labels Not FDA-approved Research use only FDA-approved Investigational Compounded (503A)
What each label means
- Not FDA-approved
- No FDA approval for any use in humans.
- Research use only
- Sold as a "research chemical" not for human use. Not FDA-approved; FDA considers such products unapproved new drugs when marketed for human use.
- FDA-approved
- FDA has approved this drug or biologic as safe and effective for its labeled use.
- Investigational
- Being studied in clinical trials; not approved by FDA for any use.
- Compounded (503A)
- Prepared by a state-licensed 503A pharmacy for an individual patient prescription. Compounded drugs are not FDA-approved.
About peptide status
Most peptides discussed here are not FDA-approved for any use, and products labeled “research use only” are not for human use. Removal from Category 2 does not authorize compounding. PCAC votes are non-binding recommendations; FDA and HHS make the final decisions.
This is not medical or legal advice, and we do not publish dosing, sourcing or reconstitution information. Talk with a licensed clinician before using any peptide.
If you think you are having a medical emergency, call 911.
Methodology
Data sources
What we include
- Peptides that are marketed to consumers through telehealth, compounding pharmacies or “research use only” sellers, or that FDA or its advisory committee has reviewed for the 503A bulks list.
- The 503A status is the one on FDA’s published lists on the “status as of” date; advisory committee votes are recorded as non-binding recommendations.
How we verify
- Every status change is dated and linked to the FDA page or meeting materials it comes from.
- Profiles are reviewed by a clinician or pharmacist on our medical review panel.
Known gaps
- 503B (outsourcing facility) status is recorded only when FDA has stated it.
- Advisory committee outcomes are sometimes reported before FDA posts minutes; those records say so.
- Human trial counts cover registered trials we reviewed, not every published study.
Update frequency: Checked at least weekly and whenever FDA updates its 503A lists or holds a PCAC meeting.
CSV columns (19)
-
profile_url - Peptide profile on this site.
-
name - Peptide name.
-
synonyms - Other names, separated by semicolons.
-
status_503a - 503A bulks-list status code.
-
status_503a_label - 503A bulks-list status in plain English.
-
status_503b - 503B (outsourcing facility) status, when known.
-
fda_approved - true when an FDA-approved drug product contains the peptide.
-
approved_product - The FDA-approved product, when there is one.
-
wada - World Anti-Doping Agency status (Prohibited, Not listed, Not assessed).
-
dea_schedule - DEA controlled-substance schedule, when assessed.
-
status_labels - Status Label codes shown on the page, separated by semicolons.
-
last_status_change - Date of the current 503A status (YYYY-MM-DD): the advisory committee vote, FDA listing or bulks-list effective date, by status.
-
status_source_url - FDA document for the current status.
-
status_as_of - Date we last verified the status.
-
human_trial_count - Registered human trials we reviewed on ClinicalTrials.gov.
-
trial_ids - ClinicalTrials.gov NCT numbers, separated by semicolons.
-
unii - FDA Unique Ingredient Identifier.
-
last_reviewed - Date of the last medical/editorial review (YYYY-MM-DD).
-
last_updated - When this record last changed (ISO 8601).
“Peptide regulatory status tracker.” Tele Launched (dataset). Updated Oct. 27, 2026. Accessed Nov. 7, 2026. https://telelaunched.com/peptides/